Treatment of Upper Airway Cough Syndrome
Start with a first-generation antihistamine (dexbrompheniramine 6 mg twice daily or azatadine 1 mg twice daily) combined with sustained-release pseudoephedrine 120 mg twice daily as first-line empiric therapy for upper airway cough syndrome. 1
Treatment Algorithm Based on Etiology
For Allergic Rhinitis-Related UACS
When allergic rhinitis is the clear trigger, you have more options:
- Nasal corticosteroids are first-line and highly effective 1
- Nonsedating antihistamines work well specifically for allergic rhinitis (unlike other UACS causes) 1
- Alternative options include nasal cromolyn, nasal antihistamines, or oral leukotriene inhibitors 1
- Avoidance of allergens when possible
Important distinction: Newer antihistamines (terfenadine, loratadine) have been shown ineffective for non-allergic UACS but work for allergic rhinitis 1. The anticholinergic properties of first-generation antihistamines are crucial for non-allergic causes.
For Postviral or Nonallergic UACS
This is where the evidence strongly favors older medications:
- First-generation antihistamine/decongestant (A/D) combinations are proven effective in randomized controlled trials 1
- The anticholinergic effect (not just antihistamine effect) is the key mechanism 1, 2
- Ipratropium bromide nasal spray can be added if A/D preparations fail or are contraindicated (e.g., glaucoma, benign prostatic hypertrophy) 1
For Chronic Rhinosinusitis
Recent evidence suggests nasal corticosteroids may be highly effective as primary treatment 3. A 2021 Japanese cohort study found that treatment centered on nasal steroids successfully resolved cough in 146 patients diagnosed with UACS.
Expected Timeline and Confirmation of Diagnosis
- Improvement should occur within days to 2 weeks of starting therapy 1
- Diagnosis is confirmed retrospectively when therapeutic intervention results in symptom resolution 4
- UACS remains a clinical diagnosis of exclusion with no pathognomonic findings 1, 4
Practical Dosing Strategy to Minimize Side Effects
To reduce sedation from first-generation antihistamines:
- Start once daily at bedtime for a few days before advancing to twice-daily dosing 1
- This approach can obviate sedation problems while maintaining efficacy
Key Contraindications and Cautions
Decongestant concerns:
- Insomnia, urinary retention (especially older men)
- Tachycardia, palpitations, worsening hypertension
- Increased intraocular pressure in glaucoma patients 1
Anticholinergic concerns:
- Urinary difficulties
- Worsening glaucoma
- Consider ipratropium as alternative when these are present 1
Common Pitfall to Avoid
Do not use newer-generation antihistamines for non-allergic UACS. Multiple studies show terfenadine and loratadine are ineffective for postviral or common cold-related cough 1. The evidence demonstrates this is not a class effect—the anticholinergic properties specific to first-generation agents are essential for efficacy 2.
When Initial Treatment Fails
If no response after 4-6 weeks of empiric treatment: